Ticker > Company >

Dhansa Labs share price

Dhansa Labs Ltd.

NSE: AMBEY SECTOR: Pesticides & Agrochemicals  8.01 K   7   1

21.30
-0.20 (-0.93%)
NSE: Today, 03:40 PM

Price Summary

Today's High

₹ 21.65

Today's Low

₹ 21.1

52 Week High

₹ 50.7

52 Week Low

₹ 20.7

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

53.14 Cr.

Enterprise Value

92.22 Cr.

No. of Shares

2.49 Cr.

P/E

11.11

P/B

0.81

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  26.4

CASH

1.76 Cr.

DEBT

40.84 Cr.

Promoter Holding

70.15 %

EPS (TTM)

₹  1.92

Sales Growth

8.96%

ROE

11.01 %

ROCE

11.43%

Profit Growth

-38.06 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.96%
3 Year15.77%
5 YearNA

Profit Growth

1 Year-38.06%
3 Year10.19%
5 YearNA

ROE%

1 Year11.01%
3 Year33.64%
5 Year32.95%

ROCE %

1 Year11.43%
3 Year19.4%
5 Year22.46%

Debt/Equity

0.6202

Price to Cash Flow

-1.54

Interest Cover Ratio

3.0451

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 70.15 0.00
Mar 2025 70.11 0.00
Sep 2024 69.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 15.7701057520226% for the Past 3 years.
  • Company has been maintaining healthy ROE of 33.6375666666667% over the past 3 years.
  • Company has a healthy liquidity position with current ratio of 2.1864.
  • The company has a high promoter holding of 70.15%.

 Limitations

  • Company has negative cash flow from operations of -34.4823.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 81.74 84.6 104.82 120.47 131.27
Total Expenditure 71.99 74.25 96.97 111.39 121.65
Operating Profit 9.75 10.35 7.85 9.08 9.62
Other Income 0.68 0.51 2.77 1.59 1.92
Interest 4.11 3.06 2.09 2.42 2.95
Depreciation 3.22 2.97 2.96 2.52 2.54
Exceptional Items 0 0 -0.06 -0.3 0
Profit Before Tax 3.09 4.83 5.5 5.43 6.04
Tax -7.25 1.26 0.26 -2.29 1.26
Net Profit 10.34 3.57 5.24 7.72 4.78
Adjusted EPS (Rs.) 21.12 2.01 2.95 4.13 1.92

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.89 17.75 17.75 18.69 24.95
Total Reserves -12.76 1.32 1.39 12.82 51.4
Borrowings 29.6 14.31 13.2 16.32 10.75
Other N/C liabilities -6.27 -4.99 -0.39 -2.14 -0.88
Current liabilities 21.92 21.58 21.63 31.04 39.58
Total Liabilities 37.39 49.96 53.59 76.74 125.79
Assets
Net Block 15.85 25.09 25.22 23.98 23.12
Capital WIP 0.95 0 0 3.84 15.66
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.46 0.45 0.46 0.5 0.48
Other N/C Assets 0 0 0 0 0
Current Assets 20.13 24.42 27.92 48.42 86.53
Total Assets 37.39 49.96 53.59 76.74 125.79
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 3.09 4.83 5.5 5.43 6.04
Adjustment 7.24 5.98 4.79 4.17 5.18
Changes in Assets & Liabilities -8.12 -5.97 -0.85 -21.5 -44.57
Tax Paid 0.53 0.77 0.61 -1.25 -1.13
Operating Cash Flow 2.74 5.61 10.05 -13.15 -34.48
Investing Cash Flow -1.17 -0.75 -3.69 -5.28 -13.5
Financing Cash Flow -1.49 -5.08 -6.23 18.39 48.34
Net Cash Flow 0.09 -0.22 0.13 -0.03 0.36

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Mar 2025% Sep 2025%
promoters 69.90 70.11 70.15
achla gupta - 0.21 0.25
rishita gupta 1.40 1.40 1.40
sarina gupta 68.49 68.49 68.49
PARTICULARS Sep 2024% Mar 2025% Sep 2025%
investors 30.10 29.89 29.85
llp 0.27 0.29 0.26
sb opportunities fund i 1.19 1.19 1.19
nakshatra stressed assets... 1.65 1.10 -
j4s venture fund-i 1.16 - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Dhansa Labs Stock Price Analysis and Quick Research Report. Is Dhansa Labs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dhansa Labs. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dhansa Labs has a PE ratio of 11.1099520133528 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dhansa Labs has ROA of 4.723% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dhansa Labs has a Current ratio of 2.1864.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dhansa Labs has a ROE of 11.012%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dhansa Labs has a Debt to Equity ratio of 0.6202 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dhansa Labs has reported revenue growth of 8.9635% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dhansa Labs for the current financial year is 7.326660567274%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dhansa Labs is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dhansa Labs is Rs 1.9172. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dhansa Labs in Ticker for free. Also, one can get the intrinsic value of Dhansa Labs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dhansa Labs FAQs

Q1. What is Dhansa Labs share price today?
Ans: The current share price of Dhansa Labs is Rs 21.3.

Q2. What is the market capitalisation of Dhansa Labs?
Ans: Dhansa Labs has a market capitalisation of Rs 53.13672447 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dhansa Labs?
Ans: The PE ratio of Dhansa Labs is 11.1099520133528 and the P/B ratio of Dhansa Labs is 0.806934331456801, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dhansa Labs share?
Ans: The 52-week high share price of Dhansa Labs is Rs 50.7, and the 52-week low share price of Dhansa Labs is Rs 20.7.

Q5. Does Dhansa Labs pay dividends?
Ans: Currently, Dhansa Labs does not pay dividends. Dividend yield of Dhansa Labs is around 0%.

Q6. What are the face value and book value of Dhansa Labs shares?
Ans: The face value of Dhansa Labs shares is Rs 10, while the book value per share of Dhansa Labs is around Rs 26.3962. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dhansa Labs?
Ans: Dhansa Labs has a total debt of Rs 40.843 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dhansa Labs?
Ans: The ROE of Dhansa Labs is 11.012% and ROCE of Dhansa Labs is 11.4277%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dhansa Labs a good buy for the long term?
Ans: The Dhansa Labs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dhansa Labs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dhansa Labs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dhansa Labs’s financials?
Ans: You can review Dhansa Labs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Dhansa Labs Share Price News

Latest updates on Dhansa Labs share price and stock news.

Last Updated on:
Brief about Dhansa Labs
X